Patent assignee · CA · COMPANY

ZENITH EPIGENETICS LTD.

25Patents
24Active
25Granted
48Portfolio score

Filing activity: Nov 20, 2013 → Jul 28, 2020

Most-cited patents

PatentTitleAreaCited byStatus
US9271978B2 Heterocyclic compounds as bromodomain inhibitors Emerging Cross-Sectional Technologies 29 Active
US9278940B2 Cyclic amines as bromodomain inhibitors Emerging Cross-Sectional Technologies 26 Active
US9765039B2 Biaryl derivatives as bromodomain inhibitors Emerging Cross-Sectional Technologies 24 Active
US9662311B2 Substituted bicyclic compounds as bromodomain inhibitors Emerging Cross-Sectional Technologies 23 Active
US9861637B2 Heterocyclic compounds as bromodomain inhibitors Emerging Cross-Sectional Technologies 21 Active
US9073878B2 Cyclic amines as bromodomain inhibitors Emerging Cross-Sectional Technologies 21 Active
US9636328B2 Substituted bicyclic compounds as bromodomain inhibitors Emerging Cross-Sectional Technologies 20 Active
US9663520B2 Bicyclic bromodomain inhibitors Emerging Cross-Sectional Technologies 16 Active
US9598367B2 Heterocyclic compounds as bromodomain inhibitors Emerging Cross-Sectional Technologies 16 Active
US9855271B2 Quinazolinones as bromodomain inhibitors Chemistry; Metallurgy 13 Active
US10363257B2 Bicyclic bromodomain inhibitors Emerging Cross-Sectional Technologies 8 Active
US10292968B2 Substituted heterocycles as bromodomain inhibitors Emerging Cross-Sectional Technologies 6 Active
US10010556B2 Bicyclic bromodomain inhibitors Emerging Cross-Sectional Technologies 3 Active
US10166215B2 Substituted bicyclic compounds as bromodomain inhibitors Emerging Cross-Sectional Technologies 1 Active
US10226451B2 Substituted bicyclic compounds as bromodomain inhibitors Emerging Cross-Sectional Technologies 1 Active
US10500209B2 Quinazolinones as bromodomain inhibitors Chemistry; Metallurgy 0 Active
US11446306B2 Bicyclic bromodomain inhibitors Emerging Cross-Sectional Technologies 0 Active
US10710992B2 Substituted pyridinones as bromodomain inhibitors Chemistry; Metallurgy 0 Active
US10231953B2 Inhibitors of bromodomains Emerging Cross-Sectional Technologies 0 Active
US12145932B2 Method of manufacturing a solid form of a BET bromodomain inhibitor Chemistry; Metallurgy 0 Active
US9999616B2 Substituted bicyclic compounds as bromodomain inhibitors General 0 Revoked
US10179125B2 Substituted pyridines as bromodomain inhibitors Emerging Cross-Sectional Technologies 0 Active
US11607405B2 Combination therapy for the treatment of triple-negative breast cancer Human Necessities 0 Active
US11026926B2 Substituted bicyclic compounds as bromodomain inhibitors Emerging Cross-Sectional Technologies 0 Active
US10772892B2 Bicyclic bromodomain inhibitors Emerging Cross-Sectional Technologies 0 Active

Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.